Universe Pharmaceuticals (UPC) Assets (2021 - 2025)
Universe Pharmaceuticals (UPC) has disclosed Assets for 5 consecutive years, with $69.3 billion as the latest value for Q3 2025.
- Quarterly Assets rose 1.99% to $69.3 billion in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $69.3 billion through Sep 2025, up 1.99% year-over-year, with the annual reading at $69.3 billion for FY2025, 1.99% up from the prior year.
- Assets hit $69.3 billion in Q3 2025 for Universe Pharmaceuticals, up from $68.0 billion in the prior quarter.
- In the past five years, Assets ranged from a high of $69.3 billion in Q3 2025 to a low of $41.7 million in Q3 2023.
- Historically, Assets has averaged $27.5 billion across 5 years, with a median of $70.1 million in 2021.
- Biggest five-year swings in Assets: fell 29.92% in 2023 and later skyrocketed 162762.16% in 2024.
- Year by year, Assets stood at $70.1 million in 2021, then dropped by 15.12% to $59.5 million in 2022, then dropped by 29.92% to $41.7 million in 2023, then surged by 162762.16% to $68.0 billion in 2024, then increased by 1.99% to $69.3 billion in 2025.
- Business Quant data shows Assets for UPC at $69.3 billion in Q3 2025, $68.0 billion in Q3 2024, and $41.7 million in Q3 2023.